Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
A Novel Rexinoid Agonist, UAB116, Decreases Metastatic Phenotype in Hepatoblastoma by Inhibiting the Wnt/β-Catenin Pathway via Upregulation of TRIM29.
Journal: International journal of molecular sciences
Published: March 24, 2025
PIM Kinase Inhibition Attenuates the Malignant Progression of Metastatic Hepatoblastoma.
Journal: International journal of molecular sciences
Published: November 01, 2023
Preclinical evidence for employing MEK inhibition in NRAS mutated pediatric gastroenteropancreatic neuroendocrine-like tumors.
Journal: Translational oncology
Published: April 11, 2023
PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4.
Journal: Clinical & experimental metastasis
Published: June 01, 2022
Serine-Threonine Kinase Receptor Associate Protein (STRAP) confers an aggressive phenotype in neuroblastoma via regulation of Focal Adhesion Kinase (FAK).
Journal: Journal of pediatric surgery
Published: January 27, 2022
Metastatic human hepatoblastoma cells exhibit enhanced tumorigenicity, invasiveness and a stem cell-like phenotype.
Journal: Journal of pediatric surgery
Published: January 15, 2022
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy.
Journal: Cancers
Published: December 23, 2021
Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines.
Journal: Cancers
Published: June 14, 2021
Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenografts.
Journal: Journal of pediatric surgery
Published: January 15, 2021
Last Updated: 09/26/2026